Treatment of Advanced Hepatocellular Carcinoma after Failure of Sorafenib Treatment: Subsequent or Additional Treatment Interventions Contribute to Prolonged Survival Postprogression

Figure 3

Kaplan-Meier survival curves for hepatocellular carcinoma patients receiving sorafenib treatment and correlations among overall survival, survival postprogression, and time to progression. (a) Overall survival. (b) Survival postprogression after first progression of sorafenib treatment. (c) Time to progression. (d) Correlation between overall survival and survival postprogression. (e) Correlation between overall survival and time to progression. The values represent Spearman’s rank correlation coefficient. The values represent the linear regression.

(a)

(b)

(c)

(d)

(e)